Kinase Inhibitors from Marine Sponges

Protein kinases play a critical role in cell regulation and their deregulation is a contributing factor in an increasing list of diseases including cancer. Marine sponges have yielded over 70 novel compounds to date that exhibit significant inhibitory activity towards a range of protein kinases. These compounds, which belong to diverse structural classes, are reviewed herein, and ordered based upon the kinase that they inhibit. Relevant synthetic studies on the marine natural product kinase inhibitors have also been included.

[1]  J. Vaquero,et al.  Palladium-mediated C–N, C–C, and C–O functionalization of azolopyrimidines: a new total synthesis of variolin B , 2008 .

[2]  B. Trost,et al.  Total synthesis of (+)-frondosin A. Application of the Ru-catalyzed [5+2] cycloaddition. , 2007, Journal of the American Chemical Society.

[3]  J. Kobayashi,et al.  Nakijiquinones G-I, new sesquiterpenoid quinones from marine sponge. , 2008, Bioorganic & medicinal chemistry.

[4]  M. Hemling,et al.  Protein kinase C inhibitors: novel spirosesquiterpene aldehydes from a marine sponge Aka (= Siphonodictyon) coralliphagum. , 1994, Journal of natural products.

[5]  David E. Williams,et al.  Meroterpenoid MAPKAP (MK2) inhibitors isolated from the indonesian marine sponge Acanthodendrilla sp. , 2004, Journal of natural products.

[6]  H. Waldmann,et al.  Development of natural product-derived receptor tyrosine kinase inhibitors based on conservation of protein domain fold. , 2003, Journal of medicinal chemistry.

[7]  Kris Novak.  Conference report--protein kinase inhibitors in cancer treatment: mixing and matching? Highlights of the keystone symposium on protein kinases and cancer; February 24-29, 2004; Lake Tahoe, California. , 2004, MedGenMed : Medscape general medicine.

[8]  A. Newton,et al.  Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.

[9]  P. Andreasen.  PAI-1 - a potential therapeutic target in cancer. , 2007, Current drug targets.

[10]  E. Eisenhauer,et al.  A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma , 2006, Sarcoma.

[11]  M. Medina,et al.  Antiangiogenic activity of aeroplysinin‐1, a brominated compound isolated from a marine sponge , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  M. Sauvain,et al.  Antiplasmodial Activities of Homogentisic Acid Derivative Protein Kinase Inhibitors Isolated from a Vanuatu Marine Sponge Pseudoceratina sp. , 2009, Marine drugs.

[13]  Jing Lin,et al.  Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo , 2007, Cancer Chemotherapy and Pharmacology.

[14]  M. Rateb,et al.  Dibenzofurans from the marine sponge-derived ascomycete Super1F1-09 , 2010 .

[15]  P. Furet,et al.  Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product. , 2000, Biochemical and biophysical research communications.

[16]  R. Wilhelm,et al.  Protein tyrosine kinase inhibitory properties of planar polycyclics obtained from the marine sponge Xestospongia cf. carbonaria and from total synthesis , 1993 .

[17]  S. Kohmoto,et al.  Isolation and structure elucidation of onnamide A, a new bioactive metabolite of a marine sponge, Theonella sp , 1988 .

[18]  R. Tyagi,et al.  Inhibitors of cyclin dependent kinases: useful targets for cancer treatment. , 2008, Current cancer drug targets.

[19]  P. Zarrinkar,et al.  High-throughput kinase profiling as a platform for drug discovery , 2008, Nature Reviews Drug Discovery.

[20]  L. Meijer,et al.  Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp. , 2006, Bioorganic & medicinal chemistry.

[21]  Jonathan C. Morris,et al.  Variolins and related alkaloids. , 2009, Chemical reviews.

[22]  K. Ang,et al.  In Vivo Antimalarial Activity of the Beta-Carboline Alkaloid Manzamine A , 2000, Antimicrobial Agents and Chemotherapy.

[23]  V. Kulcițki.  A biomimetic approach to some specifically functionalized cyclic terpenoids. , 2009, Acta biochimica Polonica.

[24]  D. Faulkner,et al.  Marine pharmacology , 2004, Antonie van Leeuwenhoek.

[25]  W. Müller,et al.  Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1. , 1990, Comparative biochemistry and physiology. B, Comparative biochemistry.

[26]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[27]  S. Danishefsky,et al.  Toward the synthesis of xestocyclamine A: investigation of double Michael reaction and direct aza Diels–Alder reaction , 2006 .

[28]  M. K. Harper,et al.  Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1). , 2002, Journal of medicinal chemistry.

[29]  M. K. Harper,et al.  Carteriosulfonic acids A-C, GSK-3beta inhibitors from a Carteriospongia sp. , 2009, Journal of natural products.

[30]  M. Tsuda,et al.  Ma'edamines A and B, cytotoxic bromotyrosine alkaloids with a unique 2(1H)pyrazinone ring from sponge Suberea sp , 2000 .

[31]  B. Strulovici,et al.  Penazetidine A, an alkaloid inhibitor of protein kinase C , 1994 .

[32]  Wael E Houssen,et al.  Bioactive diterpene derivatives from the marine sponge Spongionella sp. , 2009, Journal of natural products.

[33]  G. Bifulco,et al.  Bioactive Prenylhydroquinone Sulfates and a Novel C31 Furanoterpene Alcohol Sulfate from the Marine Sponge, Ircinia Sp. , 1995 .

[34]  S. Horinouchi,et al.  Inhibition of protein synthesis and activation of stress‐activated protein kinases by onnamide A and theopederin B, antitumor marine natural products , 2005, Cancer science.

[35]  B. Carté,et al.  Frondosins, five new sesquiterpene hydroquinone derivatives with novel skeletons from the sponge Dysidea frondosa: Inhibitors of interleukin-8 receptors , 1997 .

[36]  N. Toyooka,et al.  Model studies toward the total synthesis of halenaquinol and halenaquinone , 2002 .

[37]  D. Skropeta,et al.  Kinase Inhibitory, Haemolytic and Cytotoxic Activity of Three Deep-water Sponges from North Western Australia and their Fatty Acid Composition , 2011, Natural product communications.

[38]  P. Molina,et al.  Synthesis of the potent antitumoral marine alkaloid variolin B , 2002 .

[39]  P. Furet,et al.  Total synthesis and biological evaluation of the nakijiquinones. , 2001, Journal of the American Chemical Society.

[40]  J. Neary,et al.  Effects of marine sponge extracts on mitogen-activated protein kinase (MAPK/ERK(1,2)) activity in SW-13 human adrenal carcinoma cells. , 2001, Toxicon : official journal of the International Society on Toxinology.

[41]  D. Fabbro,et al.  New sesquiterpene quinols from a Micronesian sponge, Aka sp. , 2003, Journal of natural products.

[42]  T. Tamaoki,et al.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. , 1986, Biochemical and biophysical research communications.

[43]  G. Kroemer,et al.  Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe , 2002, Cell Death and Differentiation.

[44]  W. Kolch.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.

[45]  P. Crews,et al.  A Madagascar Sponge Batzella sp. as a source of alkylated iminosugars. , 2005, Journal of natural products.

[46]  Robin B. Kinnel,et al.  11-Hydroxystaurosporine: a highly cytotoxic, powerful protein kinase C inhibitor from a tunicate , 1992 .

[47]  J. Lazo,et al.  Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp. , 2005, Bioorganic & medicinal chemistry.

[48]  A. Bode,et al.  Marine Alkaloid Polycarpine and Its Synthetic Derivative Dimethylpolycarpine Induce Apoptosis in JB6 Cells Through p53- and Caspase 3-Dependent Pathways , 2004, Pharmaceutical Research.

[49]  L Meijer,et al.  Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. , 2000, Chemistry & biology.

[50]  Brian O Patrick,et al.  Liphagal, a Selective inhibitor of PI3 kinase alpha isolated from the sponge akacoralliphaga: structure elucidation and biomimetic synthesis. , 2006, Organic letters.

[51]  A. Marston.  Natural products as a source of protein kinase activators and inhibitors. , 2011, Current Topics in Medicinal Chemistry.

[52]  H. Gali-Muhtasib.  Cyclin-dependent kinase inhibitors from natural sources: recent advances and future prospects for cancer treatment , 2006 .

[53]  R. Isbrucker,et al.  Early Effects of Lasonolide A on Pancreatic Cancer Cells , 2009, Journal of Pharmacology and Experimental Therapeutics.

[54]  K. Inaba,et al.  Tauroacidins A and B, new bromopyrrole alkaloids possessing a taurine residue from Hymeniacidon sponge , 1997 .

[55]  M. Diaz,et al.  Evaluation of new sesquiterpene quinones from two Dysidea sponge species as inhibitors of protein tyrosine kinase , 1992 .

[56]  G. Jameson,et al.  Alkaloids from the antarctic sponge Kirkpatrickia varialosa. Part 2: Variolin A and N(3′)-methyl tetrahydrovariolin B , 1994 .

[57]  M. Boyd,et al.  (-)-Frondosins A and D, HIV-Inhibitory Sesquiterpene Hydroquinone Derivatives from Euryspongia sp , 1998 .

[58]  A. Haidour,et al.  Enantioselective total synthesis of the selective PI3 kinase inhibitor liphagal. , 2010, Organic letters.

[59]  Isolation and structure of bryostatin 1 , 1982 .

[60]  P. Crews,et al.  An alkaloid protein kinase C inhibitor, xestocyclamine A, from the marine sponge Xestospongia sp , 1993 .

[61]  R. Longley,et al.  A rapid colorimetric microassay to detect agonists/antagonists of protein kinase C based on adherence of EL-4.IL-2 cells. , 1991, The Journal of antibiotics.

[62]  L. Mazzarella,et al.  Isolation and X-ray crystal structure of a novel bromo-compound from two marine sponges , 1982 .

[63]  M. Carapancea.  Strategies to increase effectiveness of growth factor receptors-targeted therapy in glioblastoma , 2007 .

[64]  M. Tsuda,et al.  Konbu'acidin A, a new bromopyrrole alkaloid with cdk4 inhibitory activity from Hymeniacidon sponge , 1997 .

[65]  G. Hofmann,et al.  Z-Axinohydantoin and Debromo-Z-Axinohydantoin from the Sponge Stylotella aurantium: Inhibitors of Protein Kinase C , 1997 .

[66]  David O. Morgan,et al.  The Cell Cycle: Principles of Control , 2014 .

[67]  R. Willis,et al.  BRS1, a C30 bis-amino, bis-hydroxy polyunsaturated lipid from an Australian calcareous sponge that inhibits protein kinase C. , 1997, Toxicon : official journal of the International Society on Toxinology.

[68]  Kobayashi,et al.  Spongiacidins A-D, new bromopyrrole alkaloids from hymeniacidon sponge , 1998, Journal of natural products.

[69]  A. Wright,et al.  Microxine, a new cdc2 kinase inhibitor from the Australian marine sponge Microxina species. , 2001, Journal of natural products.

[70]  B. Baker,et al.  New cytotoxic sesterterpenes from the marine sponge Spongia sp , 1994 .

[71]  Burkhard Haefner,et al.  Drugs from the deep: marine natural products as drug candidates. , 2003, Drug discovery today.

[72]  A. Gossauer.  Monopyrrolic natural compounds including tetramic acid derivatives. , 2003, Fortschritte der Chemie organischer Naturstoffe = Progress in the chemistry of organic natural products. Progres dans la chimie des substances organiques naturelles.

[73]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[74]  R. Quinn,et al.  Cheilanthane sesterterpenes, protein kinase inhibitors, from a marine sponge of the genus Ircinia. , 2001, Journal of natural products.

[75]  J. Kobayashi,et al.  Nakijiquinones C and D, new sesquiterpenoid quinones with a hydroxy amino acid residue from a marine sponge inhibiting c-erbB-2 kinase , 1995 .

[76]  S. Chassaing,et al.  Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition , 2009, Marine drugs.

[77]  I. Carletti,et al.  Dihydrohymenialdisines, new pyrrole-2-aminoimidazole alkaloids from the marine sponge Cymbastela cantharella , 2011 .

[78]  Danielle Skropeta,et al.  Deep-sea natural products. , 2008, Natural product reports.

[79]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[80]  C. A. Carter,et al.  Therapeutic potential of natural compounds that regulate the activity of protein kinase C. , 2004, Current medicinal chemistry.

[81]  A. Levitzki,et al.  Tyrphostins and other tyrosine kinase inhibitors. , 2006, Annual review of biochemistry.

[82]  Ana Martínez,et al.  Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. , 2007, Journal of natural products.

[83]  P. Crews,et al.  Marine sponge polyketide inhibitors of protein tyrosine kinase. , 1992, Biochemical and biophysical research communications.

[84]  N. Fusetani,et al.  Enzyme inhibitors from marine invertebrates. , 2007, Journal of natural products.

[85]  Sean Parkin,et al.  Alkaloids from the antarctic sponge Kirkpatrickia varialosa. , 1994 .

[86]  S. Matsunaga,et al.  Theopederins A-E, potent antitumor metabolites from a marine sponge, Theonella sp. , 1992 .

[87]  J. Tepe,et al.  Preparation of hymenialdisine, analogues and their evaluation as kinase inhibitors. , 2009, Current medicinal chemistry.

[88]  F. Albericio,et al.  Total syntheses of variolin B and deoxyvariolin B. , 2003, The Journal of organic chemistry.

[89]  G. Schwartz,et al.  Bryostatin-1: A Novel PKC Inhibitor in Clinical Development , 2003, Cancer investigation.

[90]  E. Eisenhauer,et al.  ClinicalStudy A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma , 2006 .

[91]  F. Koehn,et al.  Lasonolide A, a New Cytotoxic Macrolide from the Marine Sponge Forcepia sp. , 1994 .

[92]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[93]  L. Platanias,et al.  Activation of the Mitogen- and Stress-activated Kinase 1 by Arsenic Trioxide* , 2006, Journal of Biological Chemistry.

[94]  A. Tward,et al.  Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC , 2007, Nature Medicine.

[95]  L. Meijer,et al.  Synthesis and target identification of hymenialdisine analogs. , 2004, Chemistry & biology.